Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01305590 · ClinicalTrials.gov registry record · NA
Understanding Medication Adherence Among HIV Patients
A NA study, sponsored by National Bureau of Economic Research.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01305590: Completed NA study, sponsored by National Bureau of Economic Research.
NCT01305590 is a NA study that has completed, run by National Bureau of Economic Research. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01305590, a NA study, has completed, sponsored by National Bureau of Economic Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
In anticipation of a pilot study incorporating behavioral economics into the treatment of infectious diseases, we will conduct a survey with HIV/AIDS patients at the Ponce Clinic (Infectious Disease Program of Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA).
Primary Outcome
We will measure whether participants prefer more commitment, in the form of a "Take-Medication-Get-Paid" plan; less commitment, in the form of an "Attend-Clinic-Get-Paid" plan; or if they would prefer to designate their own levels of commitment.
Interventions
- OTHER Survey to Understand Medication Adherence among HIV Patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT01305590 record still lists
NCT01305590 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Survey to Understand Medication Adherence among HIV Patients is the first listed.
NCT01305590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01305590 about?
NCT01305590 is a clinical study titled "Understanding Medication Adherence Among HIV Patients". In anticipation of a pilot study incorporating behavioral economics into the treatment of infectious diseases, we will conduct a survey with HIV/AIDS patients at the Ponce Clinic (Infectious Disease Program of Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA).
What is the current status of trial NCT01305590?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2011-07. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01305590?
The interventions under investigation include: Survey to Understand Medication Adherence among HIV Patients (OTHER).
Who is sponsoring clinical trial NCT01305590?
This trial is sponsored by National Bureau of Economic Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01305590's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia